您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报（医学版） ›› 2015, Vol. 53 ›› Issue (8): 5-10.doi: 10.6040/j.issn.1671-7554.0.2015.266

• 基础医学 • 上一篇    下一篇

1,25(OH)2D3诱导实验性自身免疫性重症肌无力大鼠免疫耐受的机制

李秀华1, 李晓丽1, 段瑞生1, 朱梅佳1, 曹莉莉2, 李衍滨1, 王思1, 岳龙涛2, 马庆海3, 刘菲1   

  1. 1. 山东大学附属千佛山医院 神经内科, 山东 济南 250014;
    2. 山东大学附属千佛山医院 医学研究中心, 山东 济南 250014;
    3. 山东大学附属千佛山医院 检验科, 山东 济南 250014
  • 收稿日期:2015-03-11 出版日期:2015-08-10 发布日期:2015-08-10
  • 通讯作者: 李秀华.E-mail:lxh731023@126.com E-mail:lxh731023@126.com
  • 基金资助:
    山东省优秀中青年科学家科研奖励基金(2008BS03012,2014BSB14078);山东省自然科学基金(ZR2010HM068)

Effects of 1,25(OH)2D3 on the induction of immune tolerance in Lewis rats with EAMG

LI Xiuhua1, LI Xiaoli1, DUAN Ruisheng1, ZHU Meijia1, CAO Lili2, LI Yanbin1, WANG Si1, YUE Longtao2, MA Qinghai3, LIU Fei1   

  1. 1. Department of Neurology, Qianfoshan Hospital Affiliated to Shandong University, Jinan 250014, Shandong, China;
    2. Central Laboratory, Qianfoshan Hospital Affiliated to Shandong University, Jinan 250014, Shandong, China;
    3. Department of Laboratory, Qianfoshan Hospital Affiliated to Shandong University, Jinan 250014, Shandong, China
  • Received:2015-03-11 Online:2015-08-10 Published:2015-08-10

PDF (PC)

147

摘要： 目的 探讨1,25-二羟维生素D3[1,25(OH)2D3]对诱导实验性自身免疫性重症肌无力(EAMG)大鼠产生免疫耐受以及免疫耐受的机制.方法 采用人工合成的大鼠来源乙酰胆碱受体α亚基97-116肽段(R97-116)免疫Lewis大鼠制备EAMG模型,随机分为1,25(OH)2D3治疗组(实验组)和对照组.进行临床症状评分、测量体质量,采用流式细胞术检测淋巴结MNC表型(CD80、CD86、MHC-II)和调节性T细胞的比例,采用CCK-8法测定特异性淋巴细胞增殖程度,采用流式细胞术测定细胞周期的分布,采用ELISA法检测淋巴结单核细胞(MNC)培养液中IL-4、IFN-γ、IL-17含量和血清中抗R97-116 IgG水平.结果 从首次免疫后28 d开始,实验组临床症状评分显著低于对照组(P <0.01).从首次免疫后35 d开始,实验组体质量显著高于对照组(P <0.01).实验组淋巴结MNC表面CD80、CD86的表达较对照组显著降低(P <0.05).实验组淋巴结MNC中CD4+CD25+T细胞和CD4+FoxP3+ T细胞的表达显著高于对照组(P <0.01,P <0.05).实验组淋巴结MNC的淋巴细胞增殖反应较对照组显著降低(P <0.01).实验组淋巴结S期细胞的百分比显著低于对照组(P <0.05),S期和G2/M期细胞的百分比也显著低于对照组(P <0.05).实验组R97-116肽激活的淋巴细胞MNC上清液中IL-4水平较对照组显著增高(P <0.05),IFN-γ和IL-17水平较对照组显著降低(P <0.05).实验组血清中抗R97-116 IgG水平显著低于对照组(P <0.05).结论 1,25(OH)2D3通过诱导免疫耐受显著地改善EAMG大鼠的临床症状,其免疫耐受机制与降低MNC表面CD80和CD86的表达、上调调节性T细胞数量和Foxp3的表达、抑制淋巴细胞增殖、改变淋巴细胞周期、Th1/Th17型细胞反应向Th2型细胞反应的转化及降低抗R97-116 IgG抗体水平有关.

关键词: 1,25-二羟维生素D3, 单核细胞, 细胞因子, 调节性T细胞, 抗R97-116 IgG, 实验性自身免疫性重症肌无力

Abstract: Objective To investigate the effects of 1,25(OH)2D3 on the induction of immune tolerance in Lewis rats with experimental autoimmune myasthenia gravis (EAMG). Methods EAMG models were established by subcutaneous injection of synthetic peptide R97-116 into both hind footpads of Lewis rats. The models were then divided into 1,25(OH)2D3 treatment group (experimental group) and control group. The clinical symptoms were evaluated. The expressions of CD80 and CD86 on MNC and Treg cells of lymph node mononuclear cells (MNC) were determined with flow cytometry. Cell proliferation was analyzed with CCK-8 test. Cell cycle was detected with flow cytometry. Cyto-kines of MNC supernatants were determined with ELISA. Serum anti-R97-116 IgG antibody was detected with ELISA. Results Compared with the control group, the experimental group exhibited lower clinical scores 28 d after first immunization (P <0.01) and less loss of body weight 35 d after first immunization (P <0.01); lower levels of CD80 and CD86 on MNC (P <0.05); higher percentages of CD4+CD25+ T cells and CD4+Foxp3+ T cells among lymph node MNC (P <0.01, P< 0.05); decreased lymphocyte proliferation in the presence of R97-116 antigen (P< 0.01); lower percentage of cells of S phase and of S phase plus G2/M phase (both P <0.05); higher level of IL-4 and lower levels of IFN-γ as well as IL-17 (all P <0.05); lower level of anti-rat R97-116 IgG antibody (P <0.05). Conclusion 1,25(OH)2D3 could ameliorate EAMG by down-regulating the expressions of CD80 and CD86 on MNC, up-regulating the number and function of Treg cells, inhibiting lymphocyte proliferation, changing the lymphocyte cell cycle, shifting cytokine profile from Th1/Th17 to Th2 type cytokines, and decreasing level of anti-R97-116 IgG antibody in serum.

Key words: Experimental autoimmune myasthenia gravis, Treg cells, Cytokines, 1,25(OH)2D3, Anti-R97-116 IgG, Mononuclear cells

中图分类号: 

  • R746.103
[1] Duan RS, Bandara AS, Huang YM, et al. Protective potential of experimental autoimmune myasthenia gravis in Lewis rats by IL-10-modified dendritic cells[J]. Neurobiol Dis, 2004, 16(2):461-467.
[2] Li XL, Liu Y, Cao LL, et al. Atorvastatin-modified dendritic cells in vitro ameliorate experimental autoimmune myasthenia gravis by up-regulated Treg cells and shifted Th1/Th17 to Th2 cytokines[J]. Mol Cell Neurosci, 2013, 56:85-95.
[3] Souroujon MC, Maiti PK, Feferman T, et al. Suppression of myasthenia gravis by antigen-specific mucosal tolerance and modulation of cytokines and costimulatory factors[J]. Ann N Y Acad Sci, 2003, 998:533-536.
[4] 胡珏, 杨欢, 肖波, 等. 树突状细胞负载Tα146-162预防实验性自身免疫性重症肌无力的实验研究[J]. 中华神经科杂志, 2006, 39(4): 224-228.
[5] 王云甫, 孙圣刚, 陈吉相, 等. 转化生长因子-β1基因修饰的树突状细胞对重症肌无力大鼠发病的干预[J]. 中华神经科杂志, 2005, 38(3):187-190.
[6] Korf H, Wenes M, Stijlemans B, et al. 1,25-Dihydroxyvitamin D3 curtails the inflammatory and T cell stimulatory capacity of macrophages through an IL-10-dependent mechanism[J]. Immunobiology, 2012, 217(12):1292-1300.
[7] Ferreira GB, Etten EV, Verstuyf A, et al. 1,25-Dihydroxyvitamin D3 alters murine dendritic cell behaviour in vitro and in vivo[J]. Diabetes Metab Res Rev, 2011, 27:933-941.
[8] Chang JH, Cha HR, Lee DS, et al. 1,25-Dihydroxyvitamin D3 inhibits the differentiation and migration of Th17 cells to protect against experimental autoimmune encephalomyelitis[J]. PLoS ONE, 2010, 5(9):12925.
[9] Ureta G, Osorio F, Morales J, et al. Generation of dendritic cells with regulatory properties[J]. Transplant Proc, 2007, 39(3):633-637.
[10] Mahon BD, Gordon SA, Cruz J, et al. Cytokine profile in patients with multiple sclerosis following vitamin D supplementation[J]. J Neuroimmunol, 2003, 134(1-2):128-132.
[11] 张凤, 富羽弘, 王维治, 等. 实验性自身免疫性脑脊髓炎大鼠中1,25二羟维生素D3的免疫调节作用[J]. 中华神经科杂志, 2005, 38(10):612-616.
[12] Baggi F, Annoni A, Ubiali F, et al. Breakdown of tolerance to a self-peptide of acetylcholine receptor alpha-subunit induces experimental myasthenia gravis in rats[J]. J Immunol, 2004, 172(4):2697-2703.
[13] Gorman S, Judge MA, Hart PH. Immune-modifying properties of topical vitamin D: Focus on dendritic cells and T cells[J]. J Steroid Biochem Mol Biol, 2010, 121(1-2):247-249.
[14] Wolden-Kirk H, Rondas D, Bugliani M, et al. Discovery of molecular pathways mediating 1,25-dihydroxyvitamin D3 protection against cytokine-induced inflammation and damage of human and male mouse islets of langerhans[J]. Endocrinology, 2014, 155(3):736-747.
[15] O'Garra A, Vieira P. Regulatory T cells and mechanisms of immune system control[J]. Nat Med, 2004, 10(8):801-805.
[16] Wang HB, Shi FD, Li H, et al. Role for interferon-gamma in rat strains with different susceptibility to experimental autoimmune myasthenia gravis[J]. Clin Immunol, 2000, 95(2):156-162.
[17] Rizzo LV, DeKruyff RH, Umetsu DT. Generation of B cell memory and affinity maturation. Induction with Th1 and Th2 T cell clones[J]. J Immunol, 1992, 148(12):3733-3739.
[18] Milani M, Ostlie N, Wu H, et al. CD4+ T and B cells cooperate in the immunoregulation of experimental autoimmune myasthenia gravis[J]. J Neuroimmunol, 2006, 179(1-2):152-162.
[19] Khoo AL, Chai LY, Koenen HJ, et al. 1,25-dihydroxyvitamin D3 modulates cytokine production induced by candida albicans: impact of seasonal variation of immune responses[J]. J Infect Dis, 2011, 203(1):122-130.
[20] Zhang H, Shih DQ, Zhang X. Mechanisms underlying effects of 1,25-dihydroxyvitamin D3 on the Th17 cells[J]. Eur J Microbiol Immunol (Bp), 2013, 3(4):237-240.
[21] Furuzawa-Carballeda J, Vargas-Rojas MI, Cabral AR. Autoimmune inflammation from the Th17 perspective[J]. Autoimmun Rev, 2007, 6(3):169-175.
[1] 李雪,李栋,时庆,周盼盼,鞠秀丽. Helios在儿童急性淋巴细胞性白血病调节性T细胞中的表达及功能[J]. 山东大学学报（医学版）, 2017, 55(4): 76-81.
[2] 王雯,刘尧,龙飞,马卫霞,苏莉莉. 外周血淋巴细胞/单核细胞比值与恶性胸膜间皮瘤患者预后的关系[J]. 山东大学学报（医学版）, 2016, 54(8): 72-77.
[3] 陈慧,李亨,岳龙涛,张民,王聪聪,王杉,张蓬,段瑞生. AG490对实验性自身免疫性重症肌无力大鼠的治疗作用[J]. 山东大学学报（医学版）, 2016, 54(4): 11-16.
[4] 余桂芳,陈树娣,陈雪竹,侯开连,梁敏. miR-916a调控SOCS6促进HBx-HepG2细胞生长[J]. 山东大学学报（医学版）, 2016, 54(12): 14-19.
[5] 袁冰,李冉冉,韩明勇. 恶性黑色素瘤调节肺组织微环境并促进肿瘤肺转移的实验研究[J]. 山东大学学报（医学版）, 2016, 54(11): 13-18.
[6] 张明明,安永辉,韩彩莉,张瑛琪,马明,李娜,邹长鹏. CIK细胞联合光动力治疗中晚期食管癌的疗效观察[J]. 山东大学学报（医学版）, 2016, 54(1): 38-41.
[7] 张蓬, 岳龙涛, 李亨, 张民, 王聪聪, 段瑞生, 窦迎春. 血脂康对实验性自身免疫性神经炎的治疗潜能[J]. 山东大学学报（医学版）, 2015, 53(2): 1-5.
[8] 冯青, 谭晓冬. L161982对大鼠实验性自身免疫性神经炎中巨噬细胞亚型变化的影响[J]. 山东大学学报（医学版）, 2015, 53(10): 21-25.
[9] 杨永荣, 李俊, 梁烨, 李近都, 蓝家富, 李天资. TNF-α-238G/A基因多态性与口腔扁平苔藓的关系[J]. 山东大学学报（医学版）, 2014, 52(S1): 10-11.
[10] 涂燕, 李振江, 汤爱平, 费妍, 李慧慧, 李剑, 贺文凤. 干扰CD147表达抑制白血病细胞SHI-1增殖及移行[J]. 山东大学学报（医学版）, 2014, 52(9): 1-5.
[11] 陈国玲, 任然, 张英辉, 宋玮, 考欣, 张晗. 大黄素对角膜炎大鼠角膜组织NF-κB活化表达的影响及意义[J]. 山东大学学报（医学版）, 2014, 52(9): 44-47.
[12] 郑加田，朱凯，孙红胜，付敏，潘正论. IL-18和MCP-1基因多态性与类风湿关节炎易感性关系的Meta分析[J]. 山东大学学报（医学版）, 2014, 52(6): 98-104.
[13] 李悦妍1，关玉庆2，苗伟2，户克庆2，胡鸿雁3，李莹2，王晓琦2，苏国海2. 阿托伐他汀对动脉粥样硬化模型兔toll样受体4及其下游信号表达的影响[J]. 山东大学学报（医学版）, 2014, 52(6): 1-6.
[14] 赵燕1，王刚1，陈大方2，程宇航1，陈雪彦1 . 首发未治精神分裂症患者IL-6、IL-10和IL-12水平及影响因素[J]. 山东大学学报（医学版）, 2014, 52(4): 70-73.
[15] 隋翔宇, 张相春, 张光永, 胡三元, 王延磊, 戴勇. 连环蛋白p120在炎性肺损伤中保护作用的初步研究[J]. 山东大学学报（医学版）, 2014, 52(12): 41-44.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发